Cloverleaf Bio, Inc. funding
Cloverleaf Bio, Inc., a biotechnology company based in New Haven, CT (founded 2023), filed a Form D with the SEC on September 9, 2026 and reported $14.8M raised of a $29.6M offering.
Amount raised$14.8M
Offering size$29.6M
Filed with the SECSeptember 9, 2026
First saleAugust 24, 2026
IndustryBiotechnology
SecuritiesEquity
LocationNew Haven, CT
Founded2023
Entity typeCorporation
Investors so far12
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 9